Opyl Ltd (OPL)

Sydney
Currency in AUD
0.027
+0.002(+8.00%)
Closed·
OPL Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
0.0260.027
52 wk Range
0.0140.033
Key Statistics
Edit
Bid/Ask
0.027 / 0.027
Prev. Close
0.025
Open
0.026
Day's Range
0.026-0.027
52 wk Range
0.014-0.033
Volume
28.63K
Average Volume (3m)
207.3K
1-Year Change
36.84%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
Show more

Opyl Ltd Company Profile

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

Opyl Ltd Earnings Call Summary for Q4/2024

  • Orange Polska reported 5% revenue growth in core telecom services, with EBITDA up 4.6% and net income rising 12% to €900+ million
  • 5G network coverage expanded to 40% of Poland's population, with fiber network reaching 9 million households
  • Company targets low single-digit EBITDA growth for 2025, plans to participate in 5G spectrum auction for 700 MHz band
  • 10% dividend increase recommended to 53 PLN per share, despite cash burn concerns highlighted by InvestingPro data
  • New mid-term strategy to be presented in March, focusing on sustaining momentum in convergence, mobile, and fiber services
Last Updated: 13/02/2025, 11:14 pm
Read Full Transcript

Compare OPL to Peers and Sector

Metrics to compare
OPL
Peers
Sector
Relationship
P/E Ratio
−2.1x−5.4x10.7x
PEG Ratio
−0.05−0.150.01
Price/Book
−16.7x2.4x2.4x
Price / LTM Sales
26.6x2.6x1.9x
Upside (Analyst Target)
-48.6%44.0%
Fair Value Upside
Unlock11.9%10.2%Unlock

Earnings

Latest Release
Feb 27, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
253.00K / --
EPS Revisions
Last 90 days

FAQ

What Is the Opyl (OPL) Stock Price Today?

The Opyl stock price today is 0.027

What Stock Exchange Does Opyl Trade On?

Opyl is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Opyl?

The stock symbol for Opyl is "OPL."

What Is the Opyl Market Cap?

As of today, Opyl market cap is 5.01M.

What is Opyl Earnings Per Share?

The Opyl EPS is -0.01.

From a Technical Analysis Perspective, Is OPL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.